| Connective tissue growth factor (CTGF) from basics to clinics Y Ramazani, N Knops, MA Elmonem, TQ Nguyen, FO Arcolino, ... Matrix Biology 68, 44-66, 2018 | 279 | 2018 |
| Simvastatin and the Rho‐kinase inhibitor Y‐27632 prevent myofibroblast transformation in Peyronie's disease‐derived fibroblasts via inhibition of YAP/TAZ nuclear translocation U Milenkovic, MM Ilg, C Zuccato, Y Ramazani, D De Ridder, M Albersen BJU international 123 (4), 703-715, 2019 | 24 | 2019 |
| Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation N Knops, J Herman, M van Dyck, Y Ramazani, E Debbaut, ... British journal of clinical pharmacology 83 (4), 863-874, 2017 | 16 | 2017 |
| Evaluation of carbohydrate-cysteamine thiazolidines as pro-drugs for the treatment of cystinosis Y Ramazani, EN Levtchenko, L Van Den Heuvel, A Van Schepdael, ... Carbohydrate research 439, 9-15, 2017 | 11 | 2017 |
| Tacrolimus induces a pro-fibrotic response in donor-derived human proximal tubule cells dependent on common variants of CYP3A5 and ABCB1 genes N Knops, Y Ramazani, HD Loor, R Goldschmeding, TQ Nguyen, ... Nephrology Dialysis Transplantation, 2022 | 6 | 2022 |
| Therapeutic concentrations of calcineurin inhibitors do not deregulate glutathione redox balance in human renal proximal tubule cells Y Ramazani, N Knops, SP Berlingerio, OC Adebayo, C Lismont, ... Plos one 16 (4), e0250996, 2021 | 6 | 2021 |
| Unravelling the mechanisms of kidney fibrosis induced by calcineurin inhibitors. Y Ramazani | | 2021 |
